Evidence map›Paper›PMID 41650299›Full record

ArticleJournal of proteome research2026

Complete Data Analysis Workflow for Quantitative DIA Mass Spectrometry Using Nextflow.

Mats Perk, Sami Pietilä, Tommi Välikangas, Balazs Balint, Tomi Suomi, Laura L Elo

Abstract read
In one paragraph

Article in Journal of proteome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mats PerkTurku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520 Turku, Finland.
Sami PietiläTurku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520 Turku, Finland.ORCID 0000-0002-3825-0967
Tommi VälikangasTurku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520 Turku, Finland.ORCID 0000-0002-6046-1920
Balazs BalintTurku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520 Turku, Finland.
Tomi SuomiTurku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520 Turku, Finland.ORCID 0000-0003-3639-979X
Laura L EloTurku Bioscience Centre, University of Turku and Åbo Akademi University, FI-20520 Turku, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Data-independent acquisition (DIA) mass spectrometry is a technique used in proteomics to identify and quantify proteins in complex biological samples. While this comprehensive approach yields more complete and reproducible protein profiles than data-independent acquisition (DDA), the resulting data are substantially larger and more complex, presenting significant challenges for data analysis and interpretation. These challenges can be effectively addressed using dedicated workflow managers that support parallel execution of complex analysis pipelines on high-performance computing infrastructure. Nextflow, in particular, is well-suited for streamlining data analysis, as it automates key aspects of workflow management, allowing researchers to efficiently analyze large-scale data sets with minimal manual intervention. Here, we describe glaDIAtor-nf, a Nextflow version of our software package glaDIAtor for untargeted analysis of DIA mass spectrometry proteomics data. We first demonstrate its technical accuracy through rigorous testing on gold standard data sets. Building on this, we then reveal known proteome patterns from public breast cancer data that remained hidden in the processed data of the original study. This illustrates the potential of reanalyzing the accumulating public data, but also highlights the need for convenient tools to facilitate such reanalysis in large-scale.

Indexed as

Mass SpectrometryProteomeProteomicsSoftwareBreast NeoplasmsData AnalysisData AnalyticsHumansWorkflowProteomedata analysisdata-independent acquisitionmass spectrometrynextflowquantitative proteomics

Identifiers

PMID41650299
PMCPMC12973368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.